国际肿瘤学杂志››2014,Vol. 41››Issue (1): 7-11.doi:10.3760/cma.j.issn.1673422X.2014.01.003
徐玥, 仲飞, 孙国平
出版日期:
2014-01-08发布日期:
2014-01-22通讯作者:
孙国平,E-mail:sunguoping@ahmu.edu.cn E-mail:sunguoping@ahmu.edu.cn基金资助:
国家自然科学基金(81071986 81272739)
XU Yue, ZHONG Fei, SUN Guo-Ping
Online:
2014-01-08Published:
2014-01-22Contact:
Sun Guoping, E-mail: sunguoping@ahmu.edu.cn E-mail:sunguoping@ahmu.edu.cn摘要:长链非编码RNA(lncRNA)是重要的基因表达调控因子,它广泛参与多种生理及病理过程。近年来研究证实lncRNA与肿瘤密切相关,并显露出作为肿瘤诊断和治疗新靶点的潜能。
徐玥, 仲飞, 孙国平. 长链非编码RNA与肿瘤[J]. 国际肿瘤学杂志, 2014, 41(1): 7-11.
XU Yue, ZHONG Fei, SUN Guo-Ping. Long non-coding RNA and tumor[J]. Journal of International Oncology, 2014, 41(1): 7-11.
[1] Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression[J]. Genome Res, 2012, 22(9):17751789. [2] Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell, 2011, 43(6):904914. [3] Gutschner T, Hmmerle M, Eissmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells[J]. Cancer Res, 2013, 73(3):11801189. [4] Schmidt LH, Spieker T, Koschmieder S, et al. The long noncoding MALAT1 RNA indicates a poor prognosis in nonsmall cell lung cancer and induces migration and tumor growth[J]. J Thorac Oncol, 2011, 6(12):19841992. [5] Tano K, Mizuno R, Okada T, et al. MALAT1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motilityrelated genes[J]. FEBS Lett, 2010, 584(22):45754580. [6] Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor BMYB[J]. PLoS Genet, 2013, 9(3):e1003368. [7] Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19derived miR675 regulates tumor suppressor RB in human colorectal cancer[J]. Carcinogenesis, 2010, 31(3):350358. [8] Zhang L, Yang F, Yuan JH, et al. Epigenetic activation of the miR200 family contributes to H19mediated metastasis suppression in hepatocellular carcinoma[J]. Carcinogenesis, 2013, 34(3):577586. [9] Huang JF, Guo YJ, Zhao CX, et al. Hepatitis B virus X protein (HBx)related long noncoding RNA (lncRNA) downregulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin[J]. Hepatology, 2013, 57(5):18821892. [10] Pan YF, Qin T, Feng L, et al. Expression profile of altered long noncoding RNAs in patients with HBVassociated hepatocellular carcinoma[J]. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(1):96101. [11] Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans[J]. Hepatology, 2011, 54(5):16791689. [12] Lu L, Zhu G, Zhang C, et al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer[J]. Breast Cancer Res Treat, 2012, 136(3):875883. [13] Nakagawa T, Endo H, Yokoyama M, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short diseasefree survival in human nonsmall cell lung cancer[J]. Biochem Biophys Res Commun, 2013, 436(2):319324. [14] Lv XB, Lian GY, Wang HR, et al. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival[J]. PLoS One, 2013, 8(5):e63516. [15] Wu W, Bhagat TD, Yang X, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1AS1, in Barrett′s esophagus and esophageal adenocarcinoma[J]. Gastroenterology, 2013, 144(5):956966. [16] Hajjari M, Behmanesh M, Sadeghizadeh M, et al. Upregulation of HOTAIR long noncoding RNA in human gastric adenocarcinoma tissues[J]. Med Oncol, 2013, 30(3):670. [17] Xu ZY, Yu QM, Du YA, et al. Knockdown of long noncoding RNA HOTAIR suppresses tumor invasion and reverses epithelialmesenchymal transition in gastric cancer[J]. Int J Biol Sci, 2013, 9(6):587597. [18] Arita T, Ichikawa D, Konishi H, et al. Circulating long noncoding RNAs in plasma of patients with gastric cancer[J]. Anticancer Res, 2013, 33(8):31853193. [19] Kam Y, Rubinstein A, Naik S, et al. Detection of a long noncoding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FITPNA molecular beacons[J]. Cancer Lett, 2013, In press. [20] Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer[J]. Genome Res, 2013, 23(9):14461461. [21] Bhan A, Hussain I, Ansari KI, et al. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol[J]. J Mol Biol, 2013, 425(19):37073722. [22] Chisholm KM, Wan Y, Li R, et al. Detection of long noncoding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma[J]. PLoS One, 2012, 7(10):e47998. [23] Augoff K, McCue B, Plow EF, et al. MiR31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triplenegative breast cancer[J]. Mol Cancer, 2012, 11:5. [24] Qin R, Chen Z, Ding Y, et al. Long noncoding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis[J]. Neoplasma, 2013, 60(5):486492. [25] Pickard MR, MourtadaMaarabouni M, Williams GT. Long noncoding RNA GAS5 regulates apoptosis in prostate cancer cell lines[J]. Biochim Biophys Acta, 2013, 1832(10):16131623. [26] Qiao HP, Gao WS, Huo JX, et al. Long noncoding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma[J]. Asian Pac J Cancer Prev, 2013, 14(2):10771082. [27] Zhang Z, Hao H, Zhang CJ, et al. Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer[J]. Zhonghua Yi Xue Za Zhi, 2012, 92(6):384387. [28] Han Y, Liu Y, Nie L, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasisassociated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder[J]. Urology, 2013, 81(1):209. |
[1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
[2] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[3] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
[4] | 陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349. |
[5] | 郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353. |
[6] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
[7] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
[8] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[9] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[10] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[11] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
[12] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
[13] | 杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279. |
[14] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
[15] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||